These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
913 related items for PubMed ID: 17949288
1. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening. Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288 [Abstract] [Full Text] [Related]
2. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants. Barton JC, Lafreniere SA, Leiendecker-Foster C, Li H, Acton RT, Press RD, Eckfeldt JH. Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796 [Abstract] [Full Text] [Related]
3. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening. Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, Eckfeldt JH, McLaren CE, Reiss JA, McLaren GD, Reboussin DM, Gordeuk VR, Speechley MR, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Am J Hematol; 2008 Feb; 83(2):126-32. PubMed ID: 17726683 [Abstract] [Full Text] [Related]
4. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study. McLaren CE, Barton JC, Gordeuk VR, Wu L, Adams PC, Reboussin DM, Speechley M, Chang H, Acton RT, Harris EL, Ruggiero AM, Castro O, Hemochromatosis and Iron Overload Screening Study Research Investigators. Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476 [Abstract] [Full Text] [Related]
5. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186 [Abstract] [Full Text] [Related]
6. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants. Acton RT, Barton JC, Leiendecker-Foster C, Zaun C, McLaren CE, Eckfeldt JH. Blood Cells Mol Dis; 2010 Apr 15; 44(4):252-6. PubMed ID: 20178892 [Abstract] [Full Text] [Related]
12. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Adams PC, Speechley M, Barton JC, McLaren CE, McLaren GD, Eckfeldt JH. Hepatology; 2012 Jun 15; 55(6):1722-6. PubMed ID: 22183642 [Abstract] [Full Text] [Related]
13. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. Acton RT, Barton JC, Passmore LV, Adams PC, Speechley MR, Dawkins FW, Sholinsky P, Reboussin DM, McLaren GD, Harris EL, Bent TC, Vogt TM, Castro O. Diabetes Care; 2006 Sep 15; 29(9):2084-9. PubMed ID: 16936157 [Abstract] [Full Text] [Related]
14. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study. McLaren CE, Barton JC, Eckfeldt JH, McLaren GD, Acton RT, Adams PC, Henkin LF, Gordeuk VR, Vulpe CD, Harris EL, Harrison BW, Reiss JA, Snively BM. Am J Hematol; 2010 Feb 15; 85(2):101-5. PubMed ID: 20095037 [Abstract] [Full Text] [Related]
15. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L. Adams PC, McLaren CE, Speechley M, McLaren GD, Barton JC, Eckfeldt JH. Can J Gastroenterol; 2013 Jul 15; 27(7):390-2. PubMed ID: 23862168 [Abstract] [Full Text] [Related]
16. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. McLaren GD, Gordeuk VR. Hematology Am Soc Hematol Educ Program; 2009 Jul 15; ():195-206. PubMed ID: 20008199 [Abstract] [Full Text] [Related]
18. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S. Vnitr Lek; 2006 Jun 15; 52(6):602-8. PubMed ID: 16871764 [Abstract] [Full Text] [Related]
19. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study. Barton JC, Acton RT, Lovato L, Speechley MR, McLaren CE, Harris EL, Reboussin DM, Adams PC, Dawkins FW, Gordeuk VR, Walker AP, Hemochromatosis and Iron Overload Screening Study Research Investigators. Clin Genet; 2006 Jan 15; 69(1):48-57. PubMed ID: 16451136 [Abstract] [Full Text] [Related]
20. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Del-Castillo-Rueda A, Moreno-Carralero MI, Cuadrado-Grande N, Alvarez-Sala-Walther LA, Enríquez-de-Salamanca R, Méndez M, Morán-Jiménez MJ. Gene; 2012 Oct 15; 508(1):15-20. PubMed ID: 22890139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]